Last reviewed · How we verify
Effects of Dapagliflozin on Epicardial Fat in Subjects With Type 2 Diabetes
The purpose of this research study is to learn about the effect of Dapagliflozin (Farxiga) on the fat of the heart.
Details
| Lead sponsor | University of Miami |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 100 |
| Start date | 2015-09 |
| Completion | 2020-09-10 |
Conditions
- Type 2 Diabetes
Interventions
- Dapagliflozin
- Metformin
- Placebo
Primary outcomes
- Epicardial Fat Thickness — At Baseline, 12 weeks, 24 weeks
Epicardial fat thickness will be measured in millimeters by treating physician using echocardiography at Baseline, 12 weeks, 24 weeks
Countries
United States